Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab. Suematsu H, Kano K, Yamada T, Hashimoto I, et al. Anticancer Res 2022;42:1535-1540.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Suematsu H, Kano K, Yamada T, Hashimoto I, et al. Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab. Anticancer Res 2022;42:1535-1540.
PMID: 35220249